Tag: Viatris
FDA Denies Approval of Needle-Free Alternative to Epinephrine Auto-injectors
The rejection was unexpected based on feedback from the FDA's expert panel in June.
Viatris, Seller of EpiPen®, Petitions FDA to Delay Approval of neffy™...
A ploy to delay introduction of neffy.
State Legislation Would Make Epinephrine Auto-Injectors More Affordable
Would cap out-of-pocket expenses to $60 per two-pack for insured and uninsured.
Viatris Responds Regarding EpiPen Family of Auto-Injectors in Light of Spectrum...
The EpiPen family of auto-injectors is NOT affected by the recall according to Viatris.
The Netherlands is Experiencing an EpiPen Shortage. Does This Portend a...
There's no need for panic, just vigilance.
Attorneys the Big Winners in Mylan $264 Million EpiPen Price Gouging...
Settlement for consumers pales in comparison to the compensation Mylan execs received while the scheme was ongoing.
Viatris — Formerly Mylan — Agrees to $264 Million Settlement to...
Company does not admit to wrongdoing in settlement.
Who Benefits Most from Pfizer’s $345M EpiPen Price Gouging Settlement? Not...
One-third of the total award will go to the law firms that represented consumers in the suit.
Exec Who Told the Food Allergy Community to F— Themselves Received...
Robert Coury is no stranger to huge bonuses despite public outcry.
